Basket - Other
HLX48-FIH101
Phase I: An open-label study to evaluate safety, tolerability, PK, PD and early signs of clinical efficacy of HLX48 (Anti-EGFRxcMET Bis ADC) in advanced or metastatic solid tumors.
Trial overview
Clinical Area
Medical Oncology
Disease
Basket
Disease site
Basket
Study Phase
I
Trial Identifiers
Registration number: NCT07473726
Principal Investigator(s)
··
··